GLP1R and Hyperglycemia: Due to their relatively high plasma levels at the time of meal intake, the short-acting GLP-1 mimetics relative to the long-acting GLP-1R agonists display a higher tendency to affect GI motility and to decrease post-prandial hyperglycemia (74).